Search by Drug Name or NDC

    NDC 36000-0282-25 FUROSEMIDE 10 mg/mL Details

    FUROSEMIDE 10 mg/mL

    FUROSEMIDE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is FUROSEMIDE.

    Product Information

    NDC 36000-0282
    Product ID 36000-282_c11792af-0cf2-4f9c-b8e7-d915b3c4d4c4
    Associated GPIs 37200030002005
    GCN Sequence Number 008205
    GCN Sequence Number Description furosemide VIAL 10 MG/ML INJECTION
    HIC3 R1M
    HIC3 Description LOOP DIURETICS
    GCN 34940
    HICL Sequence Number 003660
    HICL Sequence Number Description FUROSEMIDE
    Brand/Generic Generic
    Proprietary Name FUROSEMIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name furosemide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 10
    Active Ingredient Units mg/mL
    Substance Name FUROSEMIDE
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202747
    Listing Certified Through 2024-12-31

    Package

    NDC 36000-0282-25 (36000028225)

    NDC Package Code 36000-282-25
    Billing NDC 36000028225
    Package 25 VIAL, GLASS in 1 BOX (36000-282-25) / 2 mL in 1 VIAL, GLASS
    Marketing Start Date 2014-02-06
    NDC Exclude Flag N
    Pricing Information N/A